Rajesh Krishna, PhD

Rajesh is a scientific key opinion leader with 25+ years in drug development, specializing in model-informed strategies for biologics, vaccines, and small molecules. Currently a Distinguished Scientist at Certara, he leads strategic consulting and the CDDS centers of excellence.  Previously, he founded Merck’s quantitative clinical pharmacology department and held key roles at Aventis and Bristol-Myers Squibb. Rajesh holds a PhD in Pharmaceutical Sciences (University of British Columbia) and an MBA in Strategy and Innovation (Warwick).  Consistently recognized among the top 2% of influential scientists, his work includes 100+ publications, 89 posters, and 4 books.  He is an elected fellow of AAPS.